KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $28000.0.

  • Neogenomics' Change in Inventory fell 9877.78% to $28000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 million, marking a year-over-year decrease of 4283.07%. This contributed to the annual value of $1.5 million for FY2025, which is 4283.07% down from last year.
  • According to the latest figures from Q4 2025, Neogenomics' Change in Inventory is $28000.0, which was down 9877.78% from -$5.6 million recorded in Q3 2025.
  • In the past 5 years, Neogenomics' Change in Inventory ranged from a high of $4.1 million in Q2 2025 and a low of -$5.6 million during Q3 2025
  • Over the past 5 years, Neogenomics' median Change in Inventory value was $447000.0 (recorded in 2021), while the average stood at $208100.0.
  • The largest annual percentage gain for Neogenomics' Change in Inventory in the last 5 years was 103415.84% (2024), contrasted with its biggest fall of 201800.0% (2024).
  • Over the past 5 years, Neogenomics' Change in Inventory (Quarter) stood at $1.6 million in 2021, then tumbled by 55.38% to $697000.0 in 2022, then crashed by 71.02% to $202000.0 in 2023, then surged by 1034.16% to $2.3 million in 2024, then plummeted by 98.78% to $28000.0 in 2025.
  • Its Change in Inventory was $28000.0 in Q4 2025, compared to -$5.6 million in Q3 2025 and $4.1 million in Q2 2025.